🔗 Permalink

Inventor profile of:

Thomas H. King

City:

Denver, Colorado

Country:

United States

Published Applications:

Last publication date:

2025-01-09

Top Assignees for applications by Thomas H. King

The entities that hold a legal rights for patent applications filed by inventor King Thomas H.:

GLOBEIMMUNE, INC. 25 Louisville, CO United States
Globelmmune, Inc. 3 Louisville, CO United States
Colorado State University Research Foundation 2 Fort Collins, CO United States
The Regents of the University of Colorado, a body corporate 1 Denver, CO United States
GlobeImmune, Inc. 1 Aurora, CO United States
The Regents of the University of Coloradio 1 Denver, CO United States
The USA, as represented by the Secretary, Dept. of Health and Human Services 1 Bethesda, MD United States

Recent patent applications by King Thomas H.

Thomas H. King from Denver, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-01-09

US20250009825A1

Human necessities

LYSATES OF RECOMBINANT YEAST FOR INDUCING CELLULAR IMMUNE RESPONSES

#2 | 2021-09-23

US20210290708A1

Human necessities

METHODS AND COMPOSITIONS FOR MODULATING MYELOID-DERIVED SUPPRESSOR CELLS

#3 | 2021-05-27

US20210154250A1

Human necessities

Lysates of recombinant yeast for inducing cellular immune responses

#4 | 2020-12-17

US20200390874A1

Human necessities

Yeast-based immunotherapy and type I interferon sensitivity

#5 | 2019-08-08

US20190240320A1

Human necessities

Compositions and methods for the treatment or prevention of human immunodeficiency virus infection

#6 | 2019-05-23

US20190151429A1

Human necessities

Compositions and methods for the treatment or prevention of tuberculosis

#7 | 2018-11-01

US20180311339A1

Human necessities

Compositions and methods for the treatment or prevention of hepatitis B virus infection

#8 | 2018-08-02

US20180214525A1

Human necessities

Modified yeast-brachyury immunotherapeutic compositions

#9 | 2018-06-28

US20180177865A1

Human necessities

Compositions and methods for the treatment or prevention of human immunodeficiency virus infection

#10 | 2017-06-29

US20170182153A1

Human necessities

Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection

#11 | 2017-02-09

US20170035867A1

Human necessities

Yeast-based immunotherapy and type I interferon sensitivity

#12 | 2017-01-05

US20170000879A1

Human necessities

Compositions and methods for the treatment or prevention of hepatitis B virus infection

#13 | 2016-07-28

US20160213767A1

Human necessities

Compositions and methods for the treatment or prevention of tuberculosis

#14 | 2016-02-18

US20160045592A1

Human necessities

Compositions and methods for the treatment or prevention of human immunodeficiency virus infection

#15 | 2015-07-09

US20150191509A1

Chemistry; metallurgy

Compositions and methods for the treatment or prevention of hepatitis B virus infection

#16 | 2015-04-23

US20150110828A1

Human necessities

Yeast-based therapeutic for chronic hepatitis B infection

#17 | 2014-09-25

US20140286984A1

Human necessities

Compositions and methods for the treatment or prevention of hepatitis B virus infection

#18 | 2014-07-10

US20140193362A1

Human necessities

Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection

#19 | 2014-03-06

US20140065182A1

Human necessities

Yeast-based therapeutic for chronic hepatitis B infection

#20 | 2013-11-21

US20130309265A1

Human necessities

Yeast-based therapeutic for chronic hepatitis C infection

#21 | 2013-09-19

US20130243805A1

Chemistry; metallurgy

Compositions and methods for the treatment or prevention of hepatitis B virus infection

#22 | 2010-08-05

US20100196411A1

Human necessities

Yeast-Based Vaccine for Inducing an Immune Response

#23 | 2010-06-17

US20100150963A1

Human necessities

Yeast-based therapeutic for chronic hepatitis C infection

#24 | 2009-03-19

US20090074805A1

Human necessities

Yeast-based therapeutic for chronic hepatitis C infection

#25 | 2008-05-08

US20080107671A1

Human necessities

Yeast-based therapeutic for chronic hepatitis C infection

#26 | 2008-03-20

US20080069831A1

Human necessities

Yeast-based therapeutic for chronic hepatitis C infection

#27 | 2008-01-03

US20080003239A1

Human necessities

Yeast-based vaccine for inducing an immune response

#28 | 2006-05-25

US20060110755A1

Chemistry; metallurgy

Yeast-based therapeutic for chronic hepatitis C infection

InventorID:

443733 ⎘